: Maintains a "Strong Buy" rating with analysts citing massive revenue growth (73% YoY) driven by AI infrastructure demand.
Top Trending Stocks: US stocks with the highest interest today companies to buy stock in today
: Poised for long-term growth driven by the "boom" in GLP-1 weight-loss drugs like Mounjaro and Zepbound. : Maintains a "Strong Buy" rating with analysts